Last updated: January 28, 2021
Sponsor: Shanghai Chest Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Non-small Cell Lung Cancer
Lung Cancer
Lung Disease
Treatment
N/AClinical Study ID
NCT04730453
SHCHE202101
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Age ≥ 18 years old.
- The subject is diagnosed as multiple primary lung cancer via preoperativeimaging/pathological examination.
- Thin-slice CT images show that the ablation Lesion A is accessible/adjacent to bronchiand the size is ≤ 3 cm.
- The subject with multiple primary lung cancers can be treated with ENB-guided ablationtherapy combined with VATS according to multidisciplinary assessment.
Exclusion
Exclusion Criteria:
- The subject who cannot tolerate general anesthesia for their cardiopulmonary function,or there are other contraindications, such as uncorrectable coagulopathy.
- The situation in which the investigators think that the subject is not suitable toparticipate in this study.
Study Design
Total Participants: 30
Study Start date:
July 24, 2020
Estimated Completion Date:
December 31, 2025
Study Description
Connect with a study center
Shanghai Chest Hospital
Shanghai, Shanghai 200030
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.